Effect of verapamil versus nicardipine on 24-hour blood pressure

G. Tonolo, P. Pinna Parpaglia, C. Troffa, M. G. Melis, G. Sabino, A. Pazzola, G. Patteri, F. Pala, P. Madeddu, N. Glorioso

Research output: Contribution to journalArticlepeer-review


Thirty patients with uncomplicated, mild to moderate essential hypertension entered a comparative open study of the efficacy and tolerability of slow-release verapamil versus nicardipine. After a 2-week washout period, patients were randomly allocated to receive either verapamil SR 240 mg once daily or nicardipine 40 mg BID for 6 weeks. Lisinopril 10 mg once daily was added after 3 weeks of treatment if the sitting diastolic blood pressure was >95 mmHg. Twenty-four-hour blood pressure monitoring was performed at week 0 and after 3 and 6 weeks of treatment. Within the first 2 weeks, four patients in the nicardipine group withdrew from the study because of tachycardia (n = 2) or headache (n = 2). Three patients in both groups needed the addition of lisinopril. A significant and comparable reduction in systolic and diastolic blood pressures over 24 hours was obtained after 3 and 6 weeks with both treatments (P <0.01). We conclude that verapamil SR 240 mg once daily is an effective and well-tolerated antihypertensive drug that does not interfere with the circadian rhythm of blood pressure. Its once-a-day formulation may increase patient compliance with the antihypertensive treatment.

Original languageEnglish
Pages (from-to)1-8
Number of pages8
JournalCurrent Therapeutic Research
Issue number1
Publication statusPublished - 1993

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Effect of verapamil versus nicardipine on 24-hour blood pressure'. Together they form a unique fingerprint.

Cite this